Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, according to two agency sources familiar with the matter, STAT News’ Lizzy Lawrence reports. Pazdur informed leaders at the FDA’s drug center of his intention to leave the agency at a meeting on Tuesday. He could still retract the papers, the author notes. The move comes less than a month after he took the role at the urging of FDA Commissioner Marty Makary.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Vaccine committee considers changes to childhood schedule, NY Times reports
- Johnson & Johnson price target raised to $197 from $176 at Barclays
- Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
- Trump Trade: U.S. confirms agreement with U.K. on pharmaceutical pricing
- Is AstraZeneca’s Stock (AZN) a Good Investment Right Now?